Skip to main content

The Parasympathetic Nervous System: Function and Anatomy Study Guide

This guide provides a comprehensive overview of the parasympathetic nervous system (PSNS), a crucial component of the autonomic nervous system responsible for involuntary bodily functions. It delves into the PSNS's primary role in energy conservation, often characterized by the "rest and digest" state, and contrasts it with the "fight or flight" response. The guide explains the anatomical structure of the PSNS, including its two-neuron relay system involving preganglionic and postganglionic neur

Save this study guide to your study set

Sign up free

Your learning path

Introduction to Acetylcholine and Cholinergic Neurons

Neuroscience of Acetylcholine

Acetylcholine is a neurotransmitter synthesized from choline and acetyl coenzyme A that acts on nicotinic and muscarinic receptors to influence muscle contraction, memory, arousal, and attention.

  • acetylcholine
  • cholinergic neurons
  • nicotinic acetylcholine receptors
  • acetylcholinesterase
  • neuromuscular junctions
  • autonomic nervous system
  • basal forebrain
  • brainstem

Overview of the Parasympathetic Nervous System

The Parasympathetic Nervous System Overview

The parasympathetic nervous system is a subdivision of the autonomic nervous system that controls automatic processes like digestion, heart rate, and respiration.

  • autonomic nervous system
  • parasympathetic nervous system
  • energy conservation
  • preganglionic neurons
  • postganglionic neurons
  • ganglia
  • acetylcholine
  • brainstem
  • sacral spinal cord
  • vagus nerve

Anticholinergic and Cholinergic Toxidromes

Cholinergic and Anticholinergic Toxidromes

This video examines anticholinergic and cholinergic toxidrome signs, symptoms, and causes.

  • Anticholinergic toxidrome
  • Anticholinergic signs and symptoms
  • Anticholinergic causes
  • Cholinergic signs and symptoms
  • Cholinergic causes
  • SLUDGE mnemonic
  • Triple screen
  • Organophosphate insecticides
  • Antihistamines
  • Tricyclic anti-depressants

Neuroscience of MDMA Mechanisms

Neuroscience of MDMA Mechanisms

MDMA is a stimulant drug that inhibits transporter proteins to increase neurotransmitter activity in the synaptic cleft.

  • MDMA
  • stimulant drug
  • amphetamine
  • prosocial effects
  • transporter proteins
  • serotonin
  • dopamine
  • norepinephrine
  • synaptic cleft
  • serotonin receptor
  • oxytocin

Neuroscience of Caffeine and Adenosine Receptors

Neuroscience of Caffeine and Adenosine

Caffeine is a stimulant drug and methylxanthine that acts as an antagonist at adenosine receptors to promote wakefulness and arousal.

  • caffeine
  • methylxanthines
  • adenosine receptors
  • antagonist
  • neurotransmitters
  • dopamine
  • norepinephrine
  • wakefulness

Neuroscience of Nicotine and Acetylcholine Receptors

Neuroscience of Nicotine and Acetylcholine Receptors

Nicotine acts as an agonist at nicotinic acetylcholine receptors to cause neurotransmitter release and various behavioral effects.

  • nicotinic acetylcholine receptors
  • agonist
  • neurotransmitter release
  • depolarization
  • dopamine
  • nucleus accumbens
  • acetylcholine
  • norepinephrine
  • sympathetic nervous system
  • catecholamines
  • epinephrine
  • receptor desensitization
  • tolerance
  • upregulation

Alcoholic Effects on the Central Nervous System

Neuroscience of Alcohol Actions

Alcohol acts in the central nervous system by affecting GABA and glutamate receptors, dopamine transmission, and synaptic plasticity.

  • GABAa receptors
  • Positive allosteric modulator
  • Glutamate inhibition
  • Neural firing inhibition
  • Serotonin receptors
  • Glycine receptor function
  • Adenosine reuptake inhibition
  • Calcium channels
  • Potassium channels
  • Nicotinic acetylcholine modulation
  • Mesolimbic dopamine pathway
  • Long-term potentiation
  • Synaptic plasticity
  • Hippocampus memory disruption

Introduction to THC and Mechanism of Action

Neuroscience of THC and Cannabinoid Receptors

THC is the primary psychoactive component of cannabis that acts as a partial agonist at CB1 and CB2 G-protein coupled receptors to modulate neurotransmitter releases.

  • $\Delta^9$-tetrahydrocannabinol (THC)
  • Cannabinoids
  • Tetrahydrocannabinolic acid (THCA)
  • CB1 receptors
  • CB2 receptors
  • G-protein coupled receptors
  • Partial agonist
  • Neurotransmitter modulation
  • Analgesia
  • Cognitive function
  • Sedation
  • Euphoria

Understanding the Resting Membrane Potential

Understanding Neuronal Membrane Potential

The membrane potential of a neuron is maintained by the grouping of ions across the plasma membrane and the sodium-potassium pump.

  • plasma membrane
  • sodium ions
  • chloride ions
  • potassium ions
  • organic anions
  • resting membrane potential
  • sodium-potassium pump
  • ion channels
  • equilibrium

Understanding the Action Potential

Understanding the Neuronal Action Potential

The action potential is a momentary reversal of membrane potential that serves as the basis for electrical signaling within neurons.

  • action potential
  • membrane potential
  • resting membrane potential
  • depolarization
  • threshold membrane potential
  • sodium channels
  • sodium ions
  • rising phase
  • potassium channels
  • potassium ions
  • repolarization
  • falling phase
  • hyperpolarized
  • refractory period
  • axon terminals
  • neurotransmitters

Understanding Sleep Stages and EEG Activity

Neuroscience of Sleep Stages

Sleep stages are defined based on the measurement of electrical activity in the brain using an electroencephalogram.

  • electroencephalogram
  • EEG
  • sleep stages
  • stage 1 sleep
  • stage 2 sleep
  • sleep spindles
  • K complexes
  • stage 3 sleep
  • slow-wave sleep
  • deep sleep
  • delta waves

Stages of Sleep and REM Cycles

The sleep stages include stage 1, stage 2, stage 3, and rapid eye movement (REM) sleep characterized by EEG activity and vivid dreams.

  • Stage 1 sleep
  • Stage 2 sleep
  • Stage 3 sleep
  • Rapid eye movement (REM) sleep
  • EEG activity
  • Sleep cycles
  • Vivid dreams

Understanding Malignant Hyperthermia Susceptibility

Malignant Hyperthermia Causes and Treatment

Malignant hyperthermia is a severe reaction to certain drugs used as anesthesia for surgery and other invasive procedures.

  • malignant hyperthermia susceptibility
  • volatile anesthetics
  • depolarizing muscle relaxant
  • gene mutations
  • RYR1 gene
  • autosomal dominant inheritance
  • muscle rigidity
  • rhabdomyolysis
  • acidosis

Seizures and Pharmacological Management of Antiepileptics

Seizures and Epilepsy Manifestations

  • Seizure
  • Epilepsy
  • Convulsions
  • Tonic-clonic movements
  • Etiologic factors
  • Metabolic disorders
  • Congenital malformations
  • Genetic predisposition
  • Perinatal injury
  • Postnatal trauma
  • Myoclonic syndromes
  • Focal seizures
  • Generalized seizures
  • Electroencephalogram (EEG)
  • Prodroma
  • Aura
  • Clonic phase
  • Postictal phase

Status Epilepticus and Antiepileptic Drug Therapy

Management of status epilepticus and the use of antiepileptic drugs to control or prevent seizures through various mechanisms of action and pharmacological effects.

  • Status epilepticus
  • Pathophysiology of prolonged seizure activity
  • Antiepileptic drugs (AEDs)
  • Therapeutic drug monitoring
  • Mechanism of action of anticonvulsants
  • Adverse effects of phenytoin
  • Seizure types including partial and generalized
  • Gabapentin and GABA synthesis
  • Nursing priorities for seizure management
  • Patient education for long-term AED therapy

Understanding Guillain-Barré Syndrome

Clinical Features of Guillain Barre Syndrome

This content explains the progressive symmetrical weakness, flaccid paralysis, and paresthesia associated with Guillain Barre Syndrome.

  • Guillain Barre Syndrome
  • AIDP
  • progressive symmetrical weakness
  • ascending weakness
  • flaccid paralysis
  • paresthesia
  • respiratory involvement
  • facial muscle involvement

Guillain Barre Syndrome Subtypes and Manifestations

Guillain Barre Syndrome involves various subtypes including Miller Fisher Syndrome, acute motor and sensory axonal neuropathy, and pure sensory types characterized by autonomic nervous system involvement, respiratory muscle distress, and neurological manifestations.

  • Guillain Barre Syndrome
  • Acute motor and sensory axonal neuropathy
  • dysphagia
  • diplopia
  • dysautonomia
  • ophthalmoplegia
  • areflexia
  • ataxia
  • respiratory muscle involvement
  • autonomic nervous system features
  • pure sensory subtype
  • Pure motor type

Cholinergic and Cholinergic-Blocking Drugs

Cholinergic Drugs and Parasympathetic Stimulation

This content covers cholinergic drugs that stimulate the parasympathetic nervous system through direct-acting agonists and indirect-acting cholinesterase inhibitors.

  • Parasympathetic nervous system
  • Indirect-acting cholinergic agonists
  • Cholinesterase inhibitors
  • Acetylcholinesterase
  • Nicotinic receptors
  • Reversible and irreversible cholinesterase inhibitors
  • Donepezil
  • Pyridostigmine
  • Succinylcholine
  • Physostigmine
  • Parkinson's disease
  • Glaucoma
  • Neuromuscular blockade

Pharmacological Management of Neurological Disorders

This content discusses cholinergic drugs, cholinergic crisis, myasthenia gravis, Alzheimer's disease, Huntington's disease, and Parkinson's disease.

  • Cholinergic crisis
  • SLUDGE syndrome
  • Parasympathetic nervous system
  • Acetylcholine
  • Atropine
  • Huntington's disease
  • Basal ganglia degeneration
  • Gamma-aminobutyric acid (GABA)
  • Parkinson's disease
  • Dopaminergic nigrostriatal pathway
  • Bradykinesia
  • Hyperkinesia
  • Paroxysmal dyskinesias

Cholinergic-Blocking Drugs and Mechanisms

Cholinergic-blocking drugs, also known as anticholinergics, act as competitive antagonists that inhibit the actions of acetylcholine in the parasympathetic nervous system.

  • Cholinergic-blocking drugs
  • Competitive antagonists
  • Parasympathetic nervous system
  • Scopolamine hydrobromide
  • Dicyclomine
  • Oxybutynin
  • Tolterodine
  • Benztropine
  • Cycloplegia
  • Urinary retention
  • Decreased gastrointestinal motility
  • Decreased bronchial secretions
  • Physostigmine

Pharmacology of Parkinson's and Motor Neuron Disorders

Pharmacology and Pathophysiology of Neurological Disorders

This content discusses antiparkinsonian drug therapies, dopamine neurotransmitter imbalances, and various neurodegenerative, demyelinating, and neuromuscular junction disorders.

  • Parkinson's disease
  • Dopamine replacement therapy
  • Nondopamine dopamine receptor agonists
  • Indirect-acting dopaminergic drugs
  • MAO-B inhibitors
  • Dopamine modulators
  • COMT inhibitors
  • Anticholinergic therapy
  • Amyotrophic lateral sclerosis
  • Multiple sclerosis
  • Guillain-Barré syndrome
  • Neurotransmitter imbalance
  • Demyelinating disorders
  • Neuromuscular junction disorders

Neurological Conditions: Delirium and Dementia

Neurological Pathophysiology of Delirium

This content explores the acute brain dysfunction of delirium, comparing its clinical manifestations and neurotransmitter imbalances to dementia.

  • delirium
  • dementia
  • acute brain dysfunction
  • impaired attention
  • impaired awareness
  • impaired cognition
  • hypoxia
  • inflammation
  • neurotransmitter imbalances
  • acetylcholine deficiency
  • dopamine excess
  • hyperactive delirium
  • hypoactive delirium
  • mixed delirium
  • clinical manifestations

Neuroscience of Opioid Tolerance and Withdrawal

Neuroscience of Opioid Tolerance and Withdrawal

Exposure to opioid drugs leads to tolerance involving a decreased response to the drug and adaptive changes like a reduction in the number of functional receptors.

  • opioid tolerance
  • decreased response
  • adaptive changes
  • reduction in functional receptors
  • dysregulation
  • withdrawal effects

Benefits of Methadone Treatment

Methadone Treatment and Opioid Overdose Risks

Methadone treatment is associated with controlled doses, a lower risk of fatal and nonfatal overdose, and a reduction in intravenous drug use.

  • methadone treatment
  • opioid overdose risk
  • intravenous drug use
  • blood-borne disease risk

Anaesthetics, Neuromuscular Blockers, and Muscle Relaxants

Pharmacology of General and Local Anaesthesia

Anaesthesia drugs reduce or eliminate pain by depressing nerve function in the central nervous system and peripheral nervous system through general or local administration.

  • Local anaesthesia
  • Inhalational anaesthetics
  • Parenteral anaesthetics
  • Adjunct anaesthetics
  • Balanced anaesthesia
  • Anticholinergics
  • Opioids
  • Antihistamines
  • Benzodiazepines
  • Sedative-hypnotics
  • Overton-Meyer theory
  • Malignant hyperthermia
  • Dexmedetomidine
  • Ketamine hydrochloride
  • Nitrous oxide
  • Propofol
  • Sevoflurane
  • Procedural sedation
  • Nerve block anaesthesia

Neuromuscular Blocking Drugs and Anaesthesia

Neuromuscular blocking drugs prevent nerve transmission in skeletal and smooth muscle, resulting in muscle paralysis used with anaesthetics during surgery.

  • Neuromuscular blocking drugs
  • Nondepolarizing drugs
  • Depolarizing drugs
  • Succinylcholine
  • Vecuronium
  • Muscle paralysis
  • Endotracheal intubation
  • Anticholinesterase drugs
  • Mechanical ventilation
  • Malignant hyperthermia
  • Preoperative assessment
  • Postoperative monitoring

Muscle Relaxants Indications and Mechanisms

Muscle relaxants are used for the relief of painful musculoskeletal conditions, spasticity, and choreiform movement through CNS depression or direct action on muscle fibres.

  • Muscle relaxant indications
  • Baclofen
  • Cyclobenzaprine hydrochloride
  • Dantrolene sodium
  • Tizanidine hydrochloride
  • Mechanism of action
  • CNS depression
  • Excitation-contraction coupling
  • Sarcoplasmic reticulum
  • GABA derivatives
  • Adverse effects
  • Contraindications
  • Drug interactions
  • Nursing assessments
  • Nursing interventions

Multiple Sclerosis Types, Causes, and Diagnosis

Understanding Multiple Sclerosis Treatment and Management

Management of Multiple Sclerosis involves using intravenous corticosteroids to relieve symptoms during acute attacks and disease modifying drugs to reduce the rate of further attacks and disability.

  • intravenous corticosteroids
  • disease modifying drugs
  • interferon beta preparations
  • T and B cells modulation
  • monoclonal antibody
  • acrylizumab
  • mitosanthrone
  • siponimod
  • cladrabine
  • pharmacotherapy
  • neural Rehabilitation
  • occupational therapy

Cholinergic and Anticholinergic Medications and Neurodegenerative Disorders

Neurological Pathophysiology and Medication Applications

  • Parkinson's disease
  • Cholinergic drugs
  • Glaucoma
  • Skeletal muscle impairment
  • Airway constriction
  • Heart rate decrease
  • Vasodilation
  • Sphincter relaxation
  • Contraindications

Neurological Pathophysiology and Treatment Challenges

  • Parkinson's disease
  • Huntington's disease
  • Amyotrophic lateral sclerosis (ALS)
  • Multiple sclerosis (MS)
  • Guillain-Barré syndrome
  • Cholinergic crisis
  • Anticholinergic toxicity
  • Dopamine deficiency
  • Acetylcholine
  • Parasympathetic nervous system stimulation
  • Demyelination
  • Neurotransmitter imbalance
  • Muscle rigidity
  • Tremors
  • Postural instability

Make it your own.

Keep these readings and topics in a new study set, or add them to one you already use.